Capabilities
Early Phase & Scale-up
Gannet BioChem excels in producing small-scale PEG reagents customized to the needs of research and early-stage clinical trials. Our dedicated manufacturing suites and advanced process development capabilities ensure that every batch meets stringent quality standards.
Capabilities and Expertise
Reactor capacities
up to 200L for
flexible batch
production
Custom synthesis
tailored to your
molecule’s
requirements
Advanced analytical
methods for
consistent quality
Longstanding
relationships with
suppliers for raw
materials sourcing
Ideal for Therapeutic Innovation
Our small-scale solutions are ideal for companies innovating and developing new molecules. We help you refine your approach, preparing for eventual scale-up with confidence and precision.
Test batches for in vivo studies
Pilot production of pre-clinical GMP materials
Initial batches of custom cGMP PEG reagents
to CDMOs or in-house manufacturers
Supported by Robust Quality and Regulatory Expertise
Backed by robust quality systems and a proven approach honed through numerous FDA and client inspections, our small-scale manufacturing services deliver trusted PEG reagents to support the successful development of next-generation therapies.
Connect with
Gannet BioChem
"*" indicates required fields